COMPANY
Oui Therapeutics, Inc.
Oui Therapeutics, Inc.'s website says: "We have been involved in bringing new classes of FDA regulated products to market (including new mechanisms of action for diseases including schizophrenia)." From company website Source · Oct 13, 2026
Funding and NIH signals
- NIH award NIH awarded $967K (SBIR Phase II 4R44MH136888-03, extension, notice Jul 28, 2026). NIH RePORTER 4R44MH136888-03 (Jul 28, 2026)
Evidence (1 event)
- Jul 28, 2026 · NIH RePORTER 4R44MH136888-03
Organization: OUI THERAPEUTICS, INC; City/State: NEW HAVEN, CT; Project number: 4R44MH136888-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-07-28; FY total cost (award amount): 966804; Administering IC: National Institute of Mental Health; Project title: Development and Evaluation of a Novel Digital Therapeutic for Adults with Post-Traumatic Stress Disorder; Organization type: Domestic For-Profits
- Jul 28, 2026 · NIH RePORTER 4R44MH136888-03
Timeline
- Grant Government grant — SBIR: $966,804 (annual award, as published), announced Jul 28, 2026. Agency: NIH/NIMH. Source: government award database. source ↗
- Trial start Phase 2: Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms source ↗
- Trial start Not phased (device or behavioral study): Pilot Trial of Mobile Technology for Adolescent Suicidality source ↗
- Grant Government grant — STTR: $596,110 (annual award, as published), announced Jul 31, 2025. Agency: NIH/NIMH. Source: government award database. source ↗
- Trial start Phase 1: Feasibility of a Digital Therapeutic for Adults With Posttraumatic Stress Disorder (PTSD) source ↗
- Grant Government grant — SBIR: $417,356 (annual award, as published), announced Jun 10, 2025. Agency: NIH/NIMH. Source: government award database. source ↗
- Trial start Not phased (device or behavioral study): Feasibility of a Digital Therapeutic for Adults With Binge Eating and Obesity source ↗
- Trial start Phase 2/Phase 3: A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic source ↗
- Trial start Not phased (device or behavioral study): Feasibility Study of a Software Application for Patients Hospitalized After Suicidal Ideation or Suicide Attempts source ↗
Funding
- Government grant — SBIR: $966,804 (annual award, as published), announced Jul 28, 2026. Agency: NIH/NIMH. Source: government award database. source ↗
- Government grant — STTR: $596,110 (annual award, as published), announced Jul 31, 2025. Agency: NIH/NIMH. Source: government award database. source ↗
- Government grant — SBIR: $417,356 (annual award, as published), announced Jun 10, 2025. Agency: NIH/NIMH. Source: government award database. source ↗
Clinical trials (lead sponsor) 6
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT06868446 | Feasibility of a Digital Therapeutic for Adults With Posttraumatic Stress Disorder (PTSD) | Phase 1 | Completed | Jun 30, 2025 | Nov 18, 2025 (actual) |
| NCT07316088 | Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms | Phase 2 | Active, not recruiting | Dec 9, 2025 | Jul 31, 2026 (estimated) |
| NCT06454136 | Pilot Trial of Mobile Technology for Adolescent Suicidality | Not phased (device or behavioral study) | Enrolling by invitation | Oct 23, 2025 | 2026-06 (estimated) |
| NCT05144685 | A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic | Phase 2/Phase 3 | Terminated | Apr 7, 2022 | Jun 14, 2024 (actual) |
| NCT06454123 | Feasibility of a Digital Therapeutic for Adults With Binge Eating and Obesity | Not phased (device or behavioral study) | Unknown status (ClinicalTrials.gov) | 2024-09 | 2025-03 (estimated) |
| NCT04295382 | Feasibility Study of a Software Application for Patients Hospitalized After Suicidal Ideation or Suicide Attempts | Not phased (device or behavioral study) | Completed | May 12, 2020 | Jul 1, 2021 (actual) |
NIH awards 12
- NIH award 1R44MH136888-01 FY2024: $440,092 awarded for that fiscal year; activity R44 (SBIR); PI SIMON, PATRICIA; recipient as written: OUI THERAPEUTICS, INC, NEW HAVEN, CT. Development and Evaluation of a Novel Digi source ↗
- NIH award 3R42MH125691-03S1 FY2024: $125,443 awarded for that fiscal year; activity R42 (STTR); PI SIMON, PATRICIA; recipient as written: OUI THERAPEUTICS, INC, NEW HAVEN, CT. An Efficacy Trial of Mobile Technology f source ↗
- NIH award 6R42MH125691-03 FY2024: $480,049 awarded for that fiscal year; activity R42 (STTR); PI SIMON, PATRICIA; recipient as written: OUI THERAPEUTICS, INC, NEW HAVEN, CT. An Efficacy Trial of Mobile Technology for source ↗
- NIH award 1R41MH134704-01 FY2023: $375,273 awarded for that fiscal year; activity R41 (STTR); PI SIMON, PATRICIA; recipient as written: OUI THERAPEUTICS, INC, NEW HAVEN, CT. A Self-Guided Mobile Intervention for Adul source ↗
- NIH award 5R43MH128431-02 FY2023: $205,926 awarded for that fiscal year; activity R43 (SBIR); PI SIMON, PATRICIA; recipient as written: OUI THERAPEUTICS, INC, NEW HAVEN, CT. A Digital Psychoeducational Social Network source ↗
- NIH award 5R42MH123357-04 FY2023: $795,120 awarded for that fiscal year; activity R42 (STTR); PI SIMON, PATRICIA; recipient as written: OUI THERAPEUTICS, INC, NEW HAVEN, CT. An Efficacy Trial of a Digital Therapeutic source ↗
- NIH award 2R42MH125691-02 FY2023: $766,481 awarded for that fiscal year; activity R42 (STTR); PI SIMON, PATRICIA; recipient as written: OUI THERAPEUTICS, INC, NEW HAVEN, CT. An Efficacy Trial of Mobile Technology for source ↗
- NIH award 1R43MH128431-01A1 FY2022: $453,596 awarded for that fiscal year; activity R43 (SBIR); PI SIMON, PATRICIA; recipient as written: OUI THERAPEUTICS, INC, NEW HAVEN, CT. A Digital Psychoeducational Social Netwo source ↗
- NIH award 5R42MH123357-03 FY2022: $949,997 awarded for that fiscal year; activity R42 (STTR); PI SIMON, PATRICIA; recipient as written: OUI THERAPEUTICS, INC, NEW HAVEN, CT. An Efficacy Trial of a Digital Therapeutic source ↗
- NIH award 2R42MH123357-02 FY2021: $1,249,571 awarded for that fiscal year; activity R42 (STTR); PI SIMON, PATRICIA; recipient as written: OUI THERAPEUTICS, INC, NEW HAVEN, CT. An Efficacy Trial of a Digital Therapeut source ↗
- NIH award 1R43MH125691-01 FY2021: $398,984 awarded for that fiscal year; activity R43 (SBIR); PI FEUERSTEIN, SETH; recipient as written: OUI THERAPEUTICS, INC, NEW HAVEN, CT. Mobile Technology for Reducing and Preven source ↗
- NIH award 1R43MH123357-01 FY2020: $481,035 awarded for that fiscal year; activity R43 (SBIR); PI FEUERSTEIN, SETH; recipient as written: OUI THERAPEUTICS, INC, NEW HAVEN, CT. A Digital Therapeutic to Advance the Deli source ↗